Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.5800
0.0000
(0.00%)
At close: April 3 at 4:00:00 PM EDT
Key Executives
Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. David Ross Parkinson M.D. | President, CEO & Director | 894.02k | -- | 1950 |
| Mr. David S. Wood C.M.A., CPA, CMA, CPA, M.B.A., MBA | Chief Financial Officer | 646.76k | -- | 1957 |
| Mr. Peter A. Virsik M.B.A., M.S. | Executive VP & COO | 696.19k | -- | 1971 |
| Dr. Alessandra Cesano M.D., Ph.D. | Chief Medical Officer & Executive VP | 678.28k | -- | 1961 |
| Chandtip Chandhasin | Executive | -- | -- | -- |
| Erica Osbourne | Executive | -- | -- | -- |
| Erin Rudsinski | Executive | -- | -- | -- |
| Loleta Harris | Executive | -- | -- | -- |
| Neil Thapar | Executive | -- | -- | -- |
| Nkengyal Barber | Executive | -- | -- | -- |
ESSA Pharma Inc.
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 35
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.
Corporate Governance
ESSA Pharma Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 12, 2025 at 12:30 PM UTC - May 16, 2025 at 12:30 PM UTC
ESSA Pharma Inc. Earnings Date
Recent Events
Related Tickers
HLVX HilleVax, Inc.
1.4500
-3.33%
THRD Third Harmonic Bio, Inc.
3.5700
+0.56%
ANTX AN2 Therapeutics, Inc.
1.4000
0.00%
KZR Kezar Life Sciences, Inc.
4.5000
-2.17%
PMVP PMV Pharmaceuticals, Inc.
0.9950
-0.50%
KROS Keros Therapeutics, Inc.
10.28
+2.39%
ASMB Assembly Biosciences, Inc.
9.31
-1.69%
IKNA Ikena Oncology, Inc.
1.2000
-4.00%
RPTX Repare Therapeutics Inc.
1.0500
-1.87%
CLRB Cellectar Biosciences, Inc.
0.2932
-2.95%